N-Heterocyclic Carbene Re(I) Complexes for Antibacterial Activity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current Re(I) complexes with N-heterocyclic carbene ligands have limited understanding of their biological properties, and existing antibacterial compounds are large and unsuitable for medical use due to high molecular weight, while there is a pressing need for novel antibiotic lead structures to combat increasing bacterial resistances.
Innovation Solution
Development of N-heterocyclic carbene Re(I) complexes with unsubstituted or substituted benzimidazol-2-ylidene ligands, which exhibit high antimicrobial activity against Gram-positive bacteria and a distinct mode of action compared to existing antibiotics, potentially delaying resistance development.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing antibacterial compounds with peptide nucleic acid scaffold are used, then antibacterial activity is achieved, but molecular weight becomes too high for medical use
Solution Approach 1:
The invention extracts and isolates the essential active component (rhenium complex with N-heterocyclic carbene ligand) from the large peptide nucleic acid scaffold, removing unnecessary bulk while retaining the core antibacterial functionality through the metal complex itself
Solution Approach 2:
The invention creates a simplified molecular copy of the active antibacterial principle, using a compact rhenium complex that mimics the biological interaction of the larger compounds but with significantly reduced molecular weight suitable for medical applications
2Reliability
If conventional antibiotics are used, then bacterial infections are treated, but bacterial resistance develops
Solution Approach 1:
The invention fundamentally changes the chemical parameters and structural properties of the antibiotic agent by using a rhenium-based metal complex with N-heterocyclic carbene ligands, creating a novel mode of action that bacteria have not encountered with conventional antibiotics, thereby preventing resistance development
Solution Approach 2:
The invention creates a composite antibiotic structure combining rhenium metal center, N-heterocyclic carbene ligands, and additional coordinating ligands (L1-L5), producing a multi-component complex with unique properties that differ from single-type conventional antibiotics
3Adaptability or versatility
If Re(I) complexes with N-heterocyclic carbene ligands are developed, then structural diversity and redox properties are achieved, but biological properties remain poorly understood
Solution Approach 1:
The invention performs preliminary biological testing and characterization of the Re(I) complexes against Gram-positive bacteria before broader application, establishing baseline biological property data and mode of action information to guide future development and reduce uncertainty
Data Source
AI summary
A complex having the structure of formula (I)is disclosed. L1, L2, L3, L4, and L5 may be or include independently metal-coordinating ligands selected from the group consisting of neutral ligands, anionic ligands, and mixed ligands, and combinations thereof. In a non-limiting embodiment, the complex is an N-heterocyclic carbene (NHC) Re(I) complex having an unsubstituted or substituted benzimidazol-2-ylidene ligand. The complex may be included in a pharmaceutical composition for treating gram (+) bacterial infections.